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launched	in	2008	and	culminated	in	Access to Specialist 





















































































































































































Table 1 – Number of admissions included in the audit by NHS Trust and site
Trust Hospital Number of 
admissions
Barts Health NHS Trust Royal London* 22
Whipps Cross** 28
Brighton and Sussex University Hospitals  
NHS Trust
66




The North West London Hospitals NHS Trust Central Middlesex 1
Northwick Park 57
Guy’s and St Thomas’ NHS Foundation Trust* Evelina Children’s 6
Great Ormond Street Hospital for Children NHS 
Foundation Trust*
7
Homerton University Hospital NHS  
Foundation Trust
16
Imperial College Healthcare NHS Trust* Charing Cross 36
Hammersmith 10
Oxford University Hospitals NHS Trust* John Radcliffe 103
University College London Hospitals NHS 
Foundation Trust (including NHNN)*
37
Royal Free London NHS Foundation Trust* 45
































Individual patient level findings
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Individual patient level findings
Table 2 – Known neuromuscular condition
Neuromuscular condition Number of 
patients (%)
Neuromuscular junction disorder 55 (21.5)
Unspecified neuropathy 40 (15.6)
Diabetic neuropathy 31 (12.1)
Other specified neuropathy 21 (8.2)
Muscular Dystrophy 20 (7.8)
Inflammatory myositis 15 (5.8)
Myotonic disorders 13 (5.1)
Inflammatory neuropathy 12 (4.7)
Spinal Muscular Atrophy 9 (3.5)
Hereditary neuropathy 7 (2.7)
Mitochondrial myopathy 5 (1.9)
Other myopathy 5 (1.9)
Neuropathy secondary to 
connective tissue disorder
4 (1.6)
Metabolic disorder 4 (1.6)
Congenital myopathy 3 (1.2)
Myopathy secondary to 
connective tissue disorder
3 (1.2)
Unspecified myopathy 3 (1.2)













































Individual patient level findings
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Unplanned admissions  





























Table 3 - Number of admissions per patient































Table 4 - Preventability of admission, all 









Yes 216 (37.5) 143 (63.0)
Possibly 28 (4.9) 13 (5.7)
No 327 (56.8) 67 (29.5)
Could not be 
determined
5 (0.9) 4 (1.8)
Total 576 227
Table 5 - Measures which could prevent 

















116 (22.1) 98 (25.7)
Having an 
emergency plan
60 (11.5) 59 (15.5)
Access to/liaison 
with other services*
41 (7.8) 13 (3.4)
Prevent delay 
in referral to a 
neurology service




34 (6.5) 34 (8.9)
Prevent delay in 
initial diagnosis
29 (5.5) 8 (2.1)
Patient/parent 
education
23 (4.4) 18 (4.7)
Physiotherapy 
referral/review





15 (2.9) 4 (1.0)
Access to social 
services




3 (0.6) 0 (0.0)
Having a discharge 
plan
3 (0.6) 4 (1.0)
Better transition  
to adult care









































Table 6 - Reasons why unplanned or emergency 











First presentation of 
symptoms
111 (33.9) 0 (0.0)
Acute presentation 96 (29.4) 11 (16.4)
Required inpatient 
management
77 (23.5) 33 (49.3)
Needed tests to 
exclude a diagnosis





10 (3.1) 3 (4.5)
Failed emergency 
plan
9 (2.8) 4 (6.0)
Followed 
emergency plan
5 (1.5) 7 (10.4)
Trauma 1 (0.3) 0 (0.0)
Failed discharge 1 (0.3) 0 (0.0)
Total 327 67
Table 7 - Admissions by hospitals with and 










Preventable 139 (37.0) 77 (38.5)
‘Possibly’ 
preventable
13 (3.5) 15 (7.5)
Not preventable 221 (58.8) 106 (53.0)
Could not be 
determined













































Transfer from other hospital 72 (12.5)
Clinic 54 (9.4)
Other department/specialty 10 (1.7)
Home 2 (0.3)
Other* 4 (0.7)
Not known or recorded 6 (1.1)
Total 576




















Trauma and Orthopaedics 16 (2.8)
A&E 13 (2.2)











Ear, Nose and Throat 1 (0.2)











Unplanned admissions during the audit period


























G62 Other polyneuropathies 114 (24.6)






G71 Primary disorders of muscles 57 (12.3)
G72 Other myopathies 26 (5.6)
M33 Dermatopolymyositis 26 (5.6)
G63 Polyneuropathy in diseases 
classified elsewhere
18 (3.9)
G12 Spinal muscular atrophy and 
related syndromes
15 (3.2)
M60 Myositis 15 (3.2)
G60 Hereditary and idiopathic 
neuropathy
10 (2.2)
E74 Glycogen storage disorders 7 (1.5)
G13 Systemic atrophies primary 
affecting central nervous systems 
in diseases classified elsewhere
4 (0.9)
G73 Disorders of myoneural 
junction and muscle in diseases 
classified elsewhere
4 (0.9)
M61 Calcification and 
ossification of muscle
1 (0.2)
G61 & G62 1 (0.2)






























Neurology Consultant 107 (55.4)
Neuromuscular Consultant 63 (32.6)
Neurology Specialist Registrar (SpR) 19 (9.8)







































































Unplanned admissions during the audit period




































Access to investigations/opinion 44 (41.9)
Access to rehab/intermediate care 18 (17.1)
Social care input/package of care 17 (16.2)




Delay in transfer to another 
hospital
10 (9.5)
Access to other allied health care 
professionals
4 (3.8)




Access to orthotics 2 (1.9)





















Transfer to another hospital 49 (8.5)
Transfer back to referring 
hospital
19 (3.3)
Intermediate care 12 (2.1)
Nursing care 9 (1.5)
Back to residential care 5 (0.9)
Not applicable as patient died 26 (4.5)
Unclear or not recorded 12 (2.1)
Total 576








Delayed discharge (%) 52 (49.5) 6 (5.7) 47 (44.8) 105
No delayed discharge (%) 151 (35.1) 17 (4.0) 262 (60.6) 430
Not applicable as patient died (%) 8 (32) 5 (20.0) 12 (48.0) 25



















Figure 3 - Patient linked in with specialist 












Unplanned admissions during the audit period









Figure 4 - Patient linked in with other 







































Unplanned or emergency  
admissions in children
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Spinal Muscular Atrophy 7 (30.4)
Muscular Dystrophy 5 (21.7)
Mitochondrial myopathy 4 (17.4)
Metabolic disorder 3 (13.0)
Congenital myopathy 3 (13.0)
Hereditary neuropathy 1 (4.3)
Total 23
Table 16 - Measures which could prevent 




Access to neuromuscular services 15 (23.1)
Having an emergency plan 15 (23.1)
Surveillance of patient’s condition 8 (12.3)
Parent education and reassurance 7 (10.8)
Access to/liaison with other services* 5 (7.7)
Monitoring of repeat admissions for 
recurrent symptoms
4 (6.2)
Provision of equipment (including 
orthotics)
3 (4.6)
Having a discharge plan 3 (4.6)
Prevent delay in referral to a 
neurology service
2 (3.1)
Prevent delay in initial diagnosis 2 (3.1)




















Table 17 - Reasons why unplanned or emergency 





First presentation of symptoms 12 (30.8)
Required inpatient management 10 (25.6)
Failed emergency plan 8 (20.5)
Acute presentation 6 (15.4)
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Appendix 1: List of Trusts invited to participate
Trust Name
 Barking, Havering and Redbridge University Hospitals NHS Trust
* Barts Health NHS Trust
 Brighton and Sussex University Hospitals NHS Trust
* Cambridge University Hospitals NHS Foundation Trust
* Great Ormond Street Hospital for Children NHS Foundation Trust
* Guy’s and St Thomas’ NHS Foundation Trust
 Homerton University Hospital NHS Foundation Trust
* Imperial College Healthcare NHS Trust
* King’s College Hospital NHS Foundation Trust
 Norfolk and Norwich University Hospitals NHS Foundation Trust
 North West London Hospitals NHS Trust
* Oxford University Hospitals NHS Trust
* Royal Free London NHS Foundation Trust
* University Hospital Southampton NHS Foundation Trust
* University College London Hospitals NHS Foundation Trust





King's College Hospital Bromley Hospital






Kent and Sussex Hospital
Kent and Canterbury Hospital
Maidstone Hospital
Lewisham Hospital
Evelina Children's Hospital Medway Maritime Hospital
Kent and Canterbury Hospital
Maidstone Hospital
Chailey Hospital
Charing Cross Hospital Ealing Hospital 
St Mary's Hospital
Hillingdon Hospital 
Royal Free Hospital Welwyn Garden City Hospital
West Hertfordshire Hospital
Addenbrooke’s Hospital West Suffolk Hospital
John Radcliffe Hospital Milton Keynes Hospital
St Richard’s Hospital, Chichester









Appendix 2: List of associated outreach hospitals
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London Specialised Commissioning Group
16th	floor,	Portland	House
Stag	Place
London	SW1E	5rS
 
www.londonscg.nhs.uk
